Skip to main content
. Author manuscript; available in PMC: 2016 Jan 15.
Published in final edited form as: Cancer Res. 2015 Jan 15;75(2):270–274. doi: 10.1158/0008-5472.CAN-14-2317

Table 2.

The Associations of Incident Postmenopausal Breast Cancer Risk with Metabolic Health Defined by HOMA-IR or Insulin Levels, Stratified by Body Mass Index (BMI) Category

HOMA-IR based definition of Metabolic Health
BMI Category N (Cases/Controls) Age-adjusted HR (95% CI) P-Value Multivariate HR (95% CI) P-Value
Normal Weight (<25Kg/M2)
 Metabolically Healthy1 113/356 1.00 (Referent) 1.00 (Referent)
 Metabolically Unhealthy2 18/182 1.68 (0.85-3.33) 0.13 1.80 (0.88-3.70) 0.11
Overweight (≥25 Kg/M2)
 Metabolically Healthy1 87/339 0.93 (0.64-1.34) 0.68 0.96 (0.64-1.42) 0.83
 Metabolically Unhealthy2 169/1238 1.60 (1.12-2.28) 0.01 1.76 (1.19-2.60) 0.005

Insulin based definition of Metabolic Health
BMI Category N (Cases/Controls) Age-adjusted HR (95% CI) P-Value Multivariate HR (95% CI) P-Value
Normal Weight (<25Kg/M2)
 Metabolically Healthy3 108/352 1.00 (Referent) 1.00 (Referent)
 Metabolically Unhealthy4 19/180 1.86 (0.95-3.65) 0.07 2.06 (1.01-4.22) 0.048
Overweight (≥25 Kg/M2)
 Metabolically Healthy3 86/329 0.93 (0.64-1.35) 0.71 0.96 (0.64-1.42) 0.82
 Metabolically Unhealthy4 175/1250 1.86 (1.30-2.66) 0.001 2.01 (1.35-2.99) 0.001
1

HOMA-IR (quartile 1);

2

HOMA-IR (quartiles 3+4);

3

Insulin (quartile 1);

4

Insulin (quartiles 3+4); Adjusted for age, ethnicity, age at menarche and menopause, parity, first degree relative with breast cancer, education, alcohol consumption, physical activity, which of the two WHI studies each subject was enrolled in and, among those who participated in the clinical trials, which specific clinical trial arm they were assigned to and whether they were a member of the placebo or treatment group.